3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
9
Breast Neoplasms
7
Neoplasms
4
Lymphoma
4
Brain Neoplasms
4
Lymphoma, Non-Hodgkin
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Lymphoma, B-Cell
2
Liver Neoplasms
2
Leukemia
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma in Situ
2
Burkitt Lymphoma
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Vasculitis
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Neurofibromatosis 1
1
Interventions
fludarabine phosphate
43
Whole-Body Irradiation
36
Mycophenolic Acid
36
Peripheral Blood Stem Cell Transplantation
31
Cyclophosphamide
31
Tacrolimus
28
Busulfan
22
Antilymphocyte Serum
21
Cyclosporine
19
fludarabine
17
ruxolitinib
16
Melphalan
16
Methotrexate
15
Cytarabine
12
thymoglobulin
9
Sirolimus
9
Etoposide
9
Granulocyte Colony-Stimulating Factor
8
Filgrastim
8
Cyclosporins
8
Radiotherapy
7
Cord Blood Stem Cell Transplantation
7
Rituximab
6
Alemtuzumab
6
merphos
5
Stem Cell Transplantation
5
Flow Cytometry
5
Azacitidine
5
sargramostim
4
ponatinib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Myeloproliferative Disorders
×
Magnetic Resonance Imaging
×
Clear all
No trials found.